Long-term effect of apomorphine infusion in advanced Parkinson’s disease: a real-life study

Long-term effects of continuous subcutaneous apomorphine infusion (CSAI) on health-related quality of life (HRQoL) and predictors of CSAI discontinuation are poorly known. Data from consecutive advanced Parkinson’s disease patients treated in routine care were retrospectively collected over 24 month...

Descripción completa

Detalles Bibliográficos
Autores principales: Meira, Bruna, Degos, Bertrand, Corsetti, Elise, Doulazmi, Mohamed, Berthelot, Emeline, Virbel-Fleischman, Clara, Dodet, Pauline, Méneret, Aurélie, Mariani, Louise-Laure, Delorme, Cécile, Cormier-Dequaire, Florence, Bendetowicz, David, Villain, Nicolas, Tarrano, Clément, Mantisi, Lise, Letrillart, Hélène, Louapre, Céline, McGovern, Eavan, Worbe, Yulia, Grabli, David, Vidailhet, Marie, Hainque, Elodie, Roze, Emmanuel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8196159/
https://www.ncbi.nlm.nih.gov/pubmed/34117268
http://dx.doi.org/10.1038/s41531-021-00194-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8196159/
https://www.ncbi.nlm.nih.gov/pubmed/34117268
http://dx.doi.org/10.1038/s41531-021-00194-7

Ejemplares similares